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of Nosocomial Infections at a Tertiary Care Center in Switzerland 
Corina Ebnother, MD; Beate Tanner, MD; Flavia Schmid, MD; 
Vittoria La Rocca, RN; Ivo Heinzer, MD; Thomas Bregenzer, MD 
OBJECTIVE. To study the impact of a multimodal infection control program on the rate of nosocomial infections at a 550-bed tertiary 
care center. 
METHODS. Before and after the implementation of an infection control program, the rate of nosocomial infection was recorded in time-
interval prevalence studies. Hand hygiene compliance was studied before and after the intervention. As a surrogate marker of compliance, 
the amount of alcohol-based hand rub consumed before the intervention was compared with the amount consumed after the intervention. 
The intervention included additional staff for infection control, repeated instructions for hand hygiene, new guidelines for preoperative 
antibiotic prophylaxis, and isolation of patients infected or colonized with multidrug-resistant bacteria. 
RESULTS. The rate of nosocomial infection decreased from approximately 11.7% to 6.8% in 2 years. The rate of hand hygiene compliance 
increased by 20.0%; it was 59.0% before the intervention and increased to 79.0% afterward. These results correlate with data on the 
consumption of alcohol-based hand rub, but not with data on the use of antibiotics. 
CONCLUSION. Within 2 years, a multimodal infection control program intervention such as this one may reduce the rate of nosocomial 
infection at a tertiary care center by more than one-third and improve both the quality of care and patient outcomes. It may also generate 
considerable savings. Therefore, such programs should be promoted not only by hospital epidemiologists but also by hospital administrators. 
Infect Control Hosp Epidemiol 2008; 29:38-43 
For more than 150 years, nosocomial infection has been rec-
ognized as an important threat to hospitalized patients,1 one 
which causes up to 15,000 deaths annually in Great Britain2 
and has enormous economic consequences.3'4 The impact of 
infection control in hospitals on patients' safety, the quality 
of care, and healthcare costs has been demonstrated in several 
publications.5,6 Thus, infection control is not only an eco-
nomic issue but, even more importantly, it is an ethical ob-
ligation.7 The cost effectiveness of infection control programs 
is well documented.2'3,6 Infection control in hospitals depends 
on clinicians' awareness of epidemiologic observations in 
wards and their awareness of findings in the microbiology 
laboratory. Cooperation and communication between micro-
biologists, hospital epidemiologists, and clinical infectious 
diseases specialists is crucial for effective infection control. 
An approximately one-third reduction in the incidence of 
nosocomial infections is an achievable goal if an infection 
control unit is staffed with 2-4 full-time infection control 
professionals per 500 beds, as recommended.5,8 Prior to the 
infection control interventions, the rate of nosocomial infec-
tion at our institution was 11.7%, and the rate has been 
documented since 1999 in prevalence studies carried out in 
cooperation with the Swiss Nosocomial Infection Prevalence 
(SNIP) studies.9 In contrast to the above-mentioned staffing 
recommendation, at our 550-bed institution, only 1 full-time 
infection control nurse and a microbiologist (20% of whose 
job time was dedicated to infection control) were responsible 
for infection control until 2004. On April 1, 2004, a full-time 
hospital epidemiologist was employed, and an infection con-
trol program was initiated. We analyzed the impact of this 
program on the prevalence of nosocomial infection from 
April 1, 2004, through June 30, 2006. 
M E T H O D S 
We performed an observational study of the impact of an 
infection control program at Kantonsspital Aarau, a 550-bed 
tertiary care center in Aarau, Switzerland. On April 1, 2004, 
a full-time hospital epidemiologist was employed to imple-
ment this program. A new division for hospital hygiene and 
infection control that cooperated closely with the microbi-
ologist and the infectious diseases clinician was established. 
Studies of the program's efficacy were conducted in 2006. 
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TABLE 1. Consumption of Alcohol-Based Hand Rub During the 2-Year Study Period, by 6-Month Intervals 
Variable lul-Dec 2004 Jan-fun 2005 Jul-Dec 2005 lan-Iun 2006 
Amount of hand rub consumed, L 4,967.9 
Change from the previous period, L (%) 
4,611.2 6,089.2 6,494.9 
-356.7 (-7.2) 1,478 (32.1) 405.7 (6.7) 
NOTE. The hand hygiene intervention took place between September and December 2005. 
The main steps of the infection control program were as 
follows. 
Managing Patients Colonized and/or Infected with 
Multidrug-Resistant Bacteria 
This intervention involved the revision of guidelines for the 
management and isolation of patients who were infected and/ 
or colonized with multidrug-resistant bacteria, such as meth-
icillin-resistant Staphylococcus aureus (MRSA), extended-spec-
trum (3-lactamase (ESBL)-producing gram-negative rods, 
aminoglycoside-resistant Pseudomonas aeruginosa, and van-
comycin resistant enterococci (VRE). All isolates recovered 
from patients infected and/or colonized with MRSA were care-
fully analyzed and the strains were compared by pulsed-field 
gel electrophoresis (PFGE). The revised guidelines were com-
municated to all healthcare workers (HCWs), and instruction 
in infection control was provided for all HCWs. The infection 
control nurse was responsible for providing infection control 
instructions and ensuring that isolation guidelines were fol-
lowed in wards that had patients in isolation. 
Preoperative Antibiotic Prophylaxis 
This intervention involved analysis of the guidelines for pre-
operative antibiotic prophylaxis for surgical patients and the 
implementation of a new guideline, which was distributed on 
pocket cards. Before this intervention (ie, in January 2003) 
and afterward (ie, in November 2004), we retrospectively 
analyzed 1,000 anaesthesia protocols from surgical procedures 
to determine the rate of compliance with the guideline that 
was in place at the time. 
Bacteremia Intervention 
Previous prevalence studies had demonstrated that up to 
19.4% of nosocomial infections at our hospital were blood-
stream infections (BSIs). Pittet et al.10 showed that the at-
tributable mortality rate for nosocomial BSI is as high as 35% 
for intensive care unit patients, and the importance of early 
appropriate antibiotic treatment for these infections has been 
shown in studies by Leibovici et al.11 Therefore, in 2004, all 
patients with bacteremia were visited and assessed by the 
infectious diseases clinician. BSI was classified either as nos-
ocomial or not nosocomial, in accordance with Centers for 
Disease Control and Prevention guidelines. In addition, a 
written recommendation for antibiotic therapy was given 
to the physician responsible for each case patients with 
bacteremia. 
Hand Hygiene Education and the Distribution 
of Hand Rub 
All HCWs and cleaning personnel were repeatedly instructed 
on hand hygiene. Alcohol-based hand rub was made easily 
available, and additional dispensers were installed on the walls 
in patients' rooms and at the door of each room. In addition, 
100-mL bottles were distributed for HCWs to carry in their 
pockets. This hand hygiene program was enhanced by par-
ticipation in the Swiss Hand Hygiene Campaign (SHHC) in 
September 2005.12 As part of this campaign, hand-hygiene 
compliance was recorded according to the SHHC protocol 
both before and after the intervention. In addition, beginning 
in 2004, the hospital pharmacy recorded the consumption of 
alcohol-based hand rub at 6-month intervals. 
Timing of Studies and Analysis of Data 
In 1999, 2002, 2003, and 2004, our institution participated 
in the SNIP studies,9 which were nationwide, 1-week prev-
alence studies. To control for the efficacy of our interventions, 
in 2006 we repeated the nosocomial infection prevalence 
study using the same method and case report forms as were 
used in the national studies. Data were analyzed at the SNIP 
study center in Geneva. Categorical data were compared using 
the x2 test. A 2-sided P value of less than .05 was considered 
to be statistically significant. 
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FIGURE. Prevalence of nosocomial infection from 1999 to 2006. 
In the years prior to 2004 the mean rate of nosocomial infections 
was 11.7%. After implementation of the infection control program 
in 2004, the rate of nosocomial infections dropped to 6.8% (OR, 
0.51 [95% confidence interval, 0.27- 0.88]; P = .01). 
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TABLE 2. Estimates of the Impact of Nosocomial Infection Before and After Implementing an Infection Control Program in 2004 
Year 
Variable 1999 2002 2003 2004 2006 
Improvement, 
estimated no. of 
cases prevented 
per year" 
No. of patients 270 
No. (%) of patients with nosocomial infection 35 (13.0) 
Estimated no. of nosocomial infections per year 1,820 
Estimated no. of cases of bacteremia per year 208 
Estimated no. of deaths per year due to 
nosocomial bacteremiab 
Estimated no. of deaths per year due to all 
nosocomial infections'1 
21 
91 
253 
27 (10.7) 
1,404 
260 
26 
70 
332 
35 (10.5) 
1,820 
156 
16 
91 
328 
42 (12.8) 
2,184 
572 
57 
110 
310 
21 (6.8) 
1,092 
104 
10 
55 
715 infections 
117 infections 
35 deaths 
NOTE. Results from 1-week prevalence studies are calculated for 1 year. 
" Improvement compares the mean value prior to 2004 with the value for 2006. 
b
 We estimate that approximately 10% of the patients with nosocomial bacteremia die from this infection and that approximately 5% of all patients with 
nosocomial infections die from these infections. 
RESULTS 
Before the intervention to improve hand hygiene, hand hy-
giene compliance was observed in accordance with the stan-
dardized protocol of the SHHC, as described by Sax and 
Pittet.1213 The compliance rate (denned as a percentage of 
hand-hygiene opportunities completed appropriately) was 
59.0% for the entire hospital, and compliance rates ranged 
from 42.1% to 78.3% among different wards. Hand hygiene 
compliance increased to 79.0% after the intervention and 
repeated instruction in hand hygiene (range, 65.4%-100.0% 
compliance). The percentage of improvement in hand hy-
giene compliance in various wards ranged from 2.4% to 
42.7%. Simultaneous with the improvement in hand hygiene 
compliance, the consumption of alcohol-based hand rub 
throughout the hospital increased by 32.2% after the inter-
vention (Table 1). 
The rate of infection and/or colonization with MRSA at 
our institution has been slowly increasing, but it is still below 
2%. PFGE was performed for all strains recovered from pa-
tients at our institution. In 2005, there was an outbreak of 
MRSA colonization that involved 1 patient and 2 HCWs in 
a single ward. All patients and HCWs in the ward were 
screened for MRSA carriage by culture of nasal and pharyn-
geal swab samples. The outbreak was controlled after a few 
days, and no further transmission of MRSA has yet been 
recorded at our institution. All MRSA isolates recovered after 
this outbreak originated from outside the hospital and were 
detected by culture of screening swab samples obtained at 
admission. Less than 1% of the S. aureus isolates recovered 
at our institution were methicillin resistant in 2005 and 2006. 
The revised guideline for preoperative antibiotic prophy-
laxis was implemented in April 2004. In January 2003, the 
rate of compliance with the guidelines for preoperative an-
tibiotic prophylaxis was 29.9%. After instruction was pro-
vided and the new guideline was implemented, the compli-
ance rate improved to 54.5%. Aberration in the time of 
prophylaxis (ie, delayed or premature administration) was 
the most frequent reason that prophylaxis failed to comply 
with the guideline. In 2003, preoperative prophylaxis was 
administered at an incorrect time for 42.3% of procedures; 
in 2004, prophylaxis was administered at an incorrect time 
for 31.0% of procedures ( P < .001). Additional dosages were 
given to 26.5% of patients in 2003 and to 2.3% of patients 
in 2004 (P < .001). Prophylaxis was administered without in-
dication for 11.8% of procedures prior to the intervention, 
but only for 1% of procedures after the intervention (P = 
.002).13 
Antibiotic therapy that was not prescribed in accordance 
with the guideline was prescribed for 93 (30.5%) of 305 pa-
tients with bacteremia. For 62 of these patients (66.7%), em-
pirical therapy was switched to a narrower-spectrum agent 
or to a first-line agent. More importantly, 26 (27.5%) of these 
patients received empirical therapy that was not active against 
the organism they were known to be infected with, or they 
received no antibiotic therapy at all.14 
As an outcome parameter, the prevalence of nosocomial 
infection at our institution had been documented repeatedly 
by prevalence studies (Figure). Compared with the mean val-
TABLE 3. Estimates of the Reduction in Costs Associated With 
Nosocomial Infection 
Variable 
Estimated value 
in 2006 
No. of nosocomial infections prevented 
Cases of bacteremia prevented 
Money saved, at a cost of €3,000 
per nosocomial infection 
Estimated cost per year for additional staff 
and infrastructure 
Savings per year 
700 
110 
€2,100,000 
€200,000 
€1,900,000 
NOTE. Values for 2006 are in comparison with the period prior to 2004, 
that is, the period before the infection control program was implemented. 
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ues of studies prior to 2006 (11.7%), the nosocomial infection 
rate was reduced by 41.2% after the intervention. Before the 
intervention, between 10.5% and 13.0% of the patients were 
affected by nosocomial infections. After the intervention, the 
prevalence decreased to 6.8%. (OR for 2006 compared with 
2004, 0.5 [95% CI, 0.27-0.88]; P = .01). In 2004, the number 
of hospital admissions was 19,968, and the mean length of 
stay was 8.5 days; in 2006, there were 20,059 admissions and 
the mean length of stay was 8.5 days. We estimate that this 
infection control program prevented approximately 700 nos-
ocomial infections at our institution (Table 2). Furthermore, 
previous 1-week prevalence studies identified between 3 and 
11 (mean, 5) cases of nosocomial bacteremia per week until 
2004. In 2006, there were only 2 cases per week (x2 = 
5.86; P = .016). 
DISCUSSION 
Repeated studies of the prevalence of nosocomial infection 
in 1999, 2002, and 2003 showed a high prevalence at our 
institution. Eventually, 1 additional person (a hospital epi-
demiologist) was employed. Together with the infection con-
trol nurse, and in cooperation with the microbiologist and 
the infectious diseases clinician, an infection control program 
was implemented. Additional staff members are usually be-
lieved to generate additional costs. Therefore, it is difficult to 
convince stakeholders in hospital administrations to finance 
infection control programs, because their primary interest is 
to reduce healthcare costs.15 The potential impact of an in-
fection control program is difficult to document, and it is 
nearly impossible to achieve maximum impact if an infection 
control team is understaffed. As do most other preventive 
activities, infection control has to fight against its poor image 
in the community: prophylaxis itself does not generate profit, 
and therefore, it is not attractive. It prevents a potentially 
life-threatening situation for the patient, and it prevents costs 
for the hospital. The costs that are avoided, however, cannot 
be factored into an annual budget. The savings only become 
apparent in comparison with costs from previous years before 
preventative measures were implemented, when the rate of 
nosocomial infection was higher. In contrast, it is easy to 
calculate the costs associated with the employment of infec-
tion control staff and the improvement of infrastructure. 
Communication is crucial to overcoming this conflict be-
tween clinicians and administrators, because quality improve-
ment is often cost effective, and cooperation is the way to 
improve quality of care and reduce costs.6 Infection preven-
tion at hospitals is highly cost effective,5'616 but finances are 
not the only reason to enhance hygiene measures at hospitals. 
Ethical concerns, patient safety, and quality-of-care issues are 
the main reasons.7 
Isolation of patients—for example, those infected and/or 
colonized with MRSA—has been criticized as being ineffec-
tive and as increasing the risks for patients in isolation because 
if lowers the quality of care.1718 Cepeda et al.17 compared 
isolation with standard care in a intensive care unit where 
the rate of hand hygiene compliance was 21%; screening for 
colonization with MRSA was performed for only approxi-
mately 80% of patients, and patients were not isolated be-
tween the time screening samples were obtained and the time 
culture results were available. Thus, in that study, the spread 
of MRSA on HCWs' insufficiently disinfected hands could 
continue for 2 additional days, until culture results became 
available, or even longer if patients were not screened. The 
Cepeda et al.17 study does not document the ineffectiveness 
of isolation measures; it shows that if isolation is delayed and 
adherence to hand hygiene recommendations is low, the 
transmission of MRSA is not preventable. The combination 
of improved hand hygiene and preventive isolation during 
the time between obtaining screening samples and receiving 
culture results would probably be more effective.19 However, 
this approach is much more feasible at an institution such 
as our hospital, where there is a low prevalence of infection 
and colonization with MRSA, than it would be in a setting 
where MRSA was endemic. The goal of our multimodal in-
tervention was to maintain this low prevalence of MRSA at 
our institution and, more generally, in our area, and to reduce 
the transmission of pathogens. During the study period, there 
was no increase in the incidence of infection or colonization 
with MRSA. Our intervention may have contributed to this 
result. Observational studies do not allow for the evaluation 
of a single intervention, but they may better reflect clinical 
practice, and hence, be a more appropriate way than a ran-
domized, controlled clinical trial to show whether it is pos-
sible to prevent the spread of MRSA in a clinical setting. 
Preoperative antimicrobial prophylaxis has been estab-
lished as an important measure for decreasing the rate of 
postoperative wound infection. The efficacy of preoperative 
prophylaxis depends on the time at which it is administered.20 
It is frequently prescribed for prolonged periods and may 
contribute to the emergence of resistant pathogens.21 The 
main goal of this step of our intervention was to standardize 
the prophylaxis procedure and, therefore, increase the com-
pliance with the administration time recommended in the 
guideline and avoid unnecessary postoperative administra-
tion. The distribution of the guideline on pocket cards made 
it easily available and may have contributed to improved 
compliance and reduced antibiotic consumption. Webb et 
al.22 showed that improved preoperative use of antibiotics 
resulted in a significant decrease in surgical site infection. In 
our institution, we were not able to quantify the effect of our 
intervention on surgical site infections. However, significantly 
improved adherence to the prophylaxis guidelines may have 
had a positive impact. 
At our institution, about one-third of BSIs are hospital 
acquired.14 Up to 19% of the nosocomial infections docu-
mented during prevalence studies were BSIs. In the 1970s, 
nosocomial BSI had already been shown to cause an excess 
length of stay of 14 days and $3,600 in increased direct costs.23 
In intensive care units, nosocomial BSI causes attributable 
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costs of $40,000 per survivor, an excess length of stay of 24 
days, and an attributable mortality of 35%.10 The improved 
management of bacteremia may improve outcome24 and re-
duce costs. Therefore, in our study the infectious disease cli-
nician visited and assessed all patients with blood cultures 
positive for a pathogen. For approximately one-third of these 
patients, treatment was modified in accordance with guide-
lines. This type of intervention is a kind of secondary pre-
vention. Its goal is simply to improve the management of an 
established nosocomial BSI. However, this intervention may 
have had a positive impact on outcomes for these patients, 
as has been shown in a similar setting.24 
In contrast to other studies, our review of interventions at 
our institution did not focus on a single intervention. We 
report on a multimodal approach that represents a real-life 
situation at a tertiary care center. The most important and 
effective intervention may have been the hand hygiene cam-
paign; increased adherence to preoperative antibiotic pro-
phylaxis guidelines, supervised isolation of patients colonized 
and/or infected with muhidrug-resistant bacteria, and therapy 
recommendation for all patients with bacteremia from the 
infectious diseases clinician probably have only a minor direct 
impact on the rate of nosocomial infection. However, all of 
the interventions combined with the frequent presence of 
infectious diseases and hygiene staff in wards had an impact 
on the perception of hygiene issues and, therefore, may have 
indirectly contributed to the reduction of the nosocomial 
infection rate, which is a reliable outcome parameter. In ac-
cord with the observed reduction in the prevalence of nos-
ocomial infection, we observed, as surrogate marker, a 32% 
increase in the consumption of alcohol-based hand rub after 
the intervention. For the first time in the past 10 years, the 
hospital pharmacy did not record an increase in the con-
sumption of antibiotics, although the number of admissions 
at our hospital has been continuously increasing. The effect 
of our infection control program was greater than expected, 
but there may have been a Hawthorne effect, and the results 
may have been short lived if the interventions were not con-
tinued. To reduce this risk, the program will be continued, 
and hand hygiene compliance and prevalence rates for nos-
ocomial infection will be studied annually. 
We estimate that our infection control program reduced 
the number of nosocomial infections per year by approxi-
mately 700. Assuming a case-fatality rate of 5% for noso-
comial infection,25'26 the program may prevent approximately 
25-50 deaths per year. The costs associated with a single nos-
ocomial infection, based on the literature,2"4 range between 
€1,200 and €6,000,2 or up to $40,000 for BSIs in intensive 
care units.10 The additional length of hospital stay added by 
a nosocomial infection ranges from 1 to 11 days, and up to 
12 days for the 41% of rehospitalized patients who acquired 
nosocomial infection during their first hospital stay.26 Thus, 
our infection control program may save approximately €1.9 
million per year (Table 3). It seems to be highly cost effective, 
given that the savings are about 10 times as much as the costs 
of the program. Our program demonstrates that the reduction 
of nosocomial infection rates by about one-third5 is an achiev-
able goal. The employment of staff qualified to implement 
such a program should be one of the first goals for clinicians 
and hospital administrators, not only for economic reasons, 
but even more importantly, for ethical reasons, and to im-
prove the quality of care and patient outcomes. 
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